PCD logo

Regional Variation in Mental Health and Well-Being Among US Adolescents Aged 12 to 17 Years, 2019–2024

PEER REVIEWED

Pooled weighted prevalence of 21 psychosocial health indicators among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2019–2024. Dashed lines show national prevalence. Significant regional differences (Rao–Scott χ2 test, Benjamini–Hochberg–adjusted P < .05) were observed for psychotherapy, psychiatric medications, frequent anxiety, and frequent depression; for all adverse childhood experience indicators; for difficulty making friends and behavioral control difficulty; and for unmet medical needs, delayed medical care, no usual source of care, and no health insurance. Emotional abuse was defined as having lived with a parent or adult who frequently swore at, insulted, or put them down.
Indicator Prevalence, %
Northeast Midwest South West National
Panel A. Mental health
Psychotherapy 17.6 18.2 13.5 15.4 15.6
Psychiatric medications 11.4 15.9 12.5 10.0 12.5
Frequent (daily/weekly) anxiety 17.9 21.2 16.4 18.0 18.0
Frequent (daily/weekly) depression 6.9 8.8 6.3 7.5 7.2
Panel B. Adverse childhood experiences
Witnessed neighborhood violence 3.5 10.6 7.6 8.7 7.8
Emotional abuse 3.2 8.5 6.1 6.4 6.2
Basic needs unmet 2.1 4.5 4.1 3.3 3.7
Parent in jail 3.6 10.2 8.6 5.8 7.4
Household mental illness 6.9 13.7 10.7 10.6 10.7
Household substance use 6.0 14.5 11.4 10.5 11.0
Racial discrimination 5.8 8.0 8.8 8.3 8.1
Panel C. Functional difficulties
Learning difficulty 1.6 2.3 1.9 2.2 2.0
Remembering difficulty 1.5 2.0 1.6 1.9 1.7
Concentrating difficulty 1.2 1.1 1.6 1.8 1.5
Difficulty making friends 2.7 3.5 2.5 4.0 3.1
Behavioral control difficulty 1.9 2.7 3.4 2.5 2.8
Panel D. Health care access
Poor/fair health 2.6 3.1 3.3 3.5 3.2
Unmet medical needs 0.5 1.0 1.7 1.3 1.3
Delayed medical care 0.5 1.0 1.9 1.7 1.4
No usual source of care 1.2 3.2 3.8 2.9 3.0
No health insurance 1.8 4.0 7.5 3.8 5.0


Figure 1. Pooled weighted prevalence of 21 psychosocial health indicators among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2019–2024. Dashed lines show national prevalence. Significant regional differences (Rao–Scott χ2 test, Benjamini–Hochberg–adjusted P < .05) were observed for psychotherapy, psychiatric medications, frequent anxiety, and frequent depression; for all adverse childhood experience indicators; for difficulty making friends and behavioral control difficulty; and for unmet medical needs, delayed medical care, no usual source of care, and no health insurance. Emotional abuse was defined as having lived with a parent or adult who frequently swore at, insulted, or put them down.

Return to Article

Annual weighted prevalence of mental health indicators among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2019–2024. Dashed line shows national prevalence. 2020 Northeast data for frequent depression did not meet National Center for Health Statistics standards for proportions and should be interpreted with caution.
Indicator/year Prevalence, %
Northeast Midwest South West National
Panel A. Therapy/counseling
2019 17.7 13.3 10.0 11.4 12.3
2020 15.4 17.1 13.0 13.5 14.4
2021 13.3 17.1 12.9 15.1 14.4
2022 21.1 21.0 14.9 19.3 18.2
2023 17.4 21.2 15.6 15.2 16.9
2024 20.3 19.6 14.4 18.1 17.3
Panel B. Psychiatric medication
2019 10.8 13.1 11.2 8.4 10.8
2020 12.7 17.3 10.6 9.0 12.0
2021 7.7 12.3 11.5 9.0 10.5
2022 12.4 15.6 13.3 12.5 13.4
2023 11.0 20.7 14.4 11.4 14.5
2024 13.8 16.2 14.0 9.7 13.4
Panel C. Frequent anxiety (daily/weekly)
2019 16.1 18.5 12.3 13.6 14.5
2020 17.9 19.7 12.9 17.6 16.3
2021 14.1 19.6 15.9 17.8 16.8
2022 25.7 24.8 20.2 23.5 22.8
2023 14.4 22.6 19.1 20.0 19.3
2024 18.5 22.0 17.8 15.3 18.2
Panel D. Frequent depression (daily/weekly)
2019 6.7 8.9 5.6 6.1 6.6
2020 7.3 7.6 6.0 8.7 7.2
2021 6.7 9.6 5.8 7.3 7.1
2022 10.2 10.0 8.0 8.7 9.0
2023 6.4 8.8 6.8 7.9 7.4
2024 4.1 7.8 5.8 6.1 6.0


Figure 2. Annual weighted prevalence of mental health indicators among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2019–2024. Dashed line shows national prevalence. 2020 Northeast data for frequent depression did not meet National Center for Health Statistics standards for proportions and should be interpreted with caution.

Return to Article

Annual weighted prevalence of adverse childhood experience indicators among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2021–2023. Dashed line shows national prevalence. 2021 Northeast data for emotional abuse did not meet National Center for Health Statistics standards for proportions and should be interpreted with caution. Emotional abuse was defined as having lived with a parent or adult who frequently swore at, insulted, or put them down.
Indicator/year Prevalence, %
Northeast Midwest South West National
Panel A. Witnessed neighborhood violence
2021 3.4 9.8 6.6 7.1 6.9
2022 3.7 11.2 7.8 9.6 8.3
2023 3.5 10.8 8.5 9.2 8.4
Panel B. Emotional abuse
2021 3.3 8.4 5.9 4.2 5.6
2022 3.9 8.1 7.8 7.8 7.3
2023 2.3 8.9 4.6 7.1 5.8
Panel C. Basic needs not met
2021 1.0 3.5 3.2 2.8 2.8
2022 3.2 4.9 5.3 4.0 4.6
2023 2.2 5.0 3.7 3.2 3.6
Panel D. Parent in jail
2021 3.6 7.6 7.3 5.4 6.4
2022 3.8 12.1 9.6 6.4 8.4
2023 3.4 10.8 8.8 5.5 7.6
Panel E. Household mental illness
2021 8.9 11.9 10.6 8.7 10.1
2022 5.8 16.4 12.3 12.3 12.1
2023 6.1 12.7 9.3 10.8 9.9
Panel F. Household substance use
2021 4.4 14.9 9.4 9.8 9.8
2022 8.3 13.8 14.1 12.9 12.8
2023 5.1 14.9 10.8 8.8 10.3
Panel G. Racial discrimination
2021 6.3 6.9 8.2 8.7 7.8
2022 3.9 9.4 8.3 9.0 8.0
2023 7.3 7.7 10.0 7.3 8.4


Figure 3. Annual weighted prevalence of adverse childhood experience indicators among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2021–2023. Dashed line shows national prevalence. 2021 Northeast data for emotional abuse did not meet National Center for Health Statistics standards for proportions and should be interpreted with caution. Emotional abuse was defined as having lived with a parent or adult who frequently swore at, insulted, or put them down.

Return to Article

Annual weighted prevalence of functional difficulties among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2019–2024. Dashed line shows national prevalence. Some yearly regional estimates did not meet National Center for Health Statistics reliability standards and should be interpreted with caution: 2020 Northeast data for difficulty learning, remembering, and concentrating; 2020 Midwest data for difficulty with behavioral control and making friends; and 2021 Midwest data for difficulty concentrating.
Difficulty/year Prevalence, %
Northeast Midwest South West National
Panel A. Learning
2019 1.7 1.7 1.7 1.6 1.7
2020 3.1 3.8 1.4 2.6 2.5
2021 2.0 1.9 2.3 2.7 2.2
2022 0.6 1.6 1.6 2.0 1.5
2023 0.7 2.4 2.1 2.6 2.1
2024 1.4 2.3 2.6 1.8 2.2
Panel B. Remembering
2019 1.1 2.1 1.7 1.1 1.5
2020 2.0 2.7 1.1 1.5 1.7
2021 1.6 1.0 1.2 2.4 1.5
2022 1.8 2.4 1.2 1.7 1.7
2023 1.3 1.7 2.3 2.3 2.0
2024 1.2 2.0 2.1 2.5 2.0
Panel C. Concentrating
2019 1.3 0.9 0.9 1.3 1.1
2020 3.6 0.9 1.0 2.9 1.8
2021 0.4 0.0 2.2 1.5 1.3
2022 0.4 1.1 1.4 1.2 1.2
2023 0.3 1.8 2.1 2.7 1.9
2024 1.1 1.5 1.8 1.3 1.5
Panel D. Making friends
2019 2.1 3.8 2.9 1.8 2.7
2020 2.9 4.8 1.5 6.3 3.6
2021 2.5 2.7 3.2 3.6 3.1
2022 3.7 2.4 2.0 4.2 2.9
2023 2.0 4.0 3.0 4.8 3.5
2024 3.2 3.4 2.3 3.1 2.9
Panel E. Behavioral control
2019 1.9 2.2 3.3 1.4 2.4
2020 1.6 3.7 2.5 2.4 2.6
2021 1.5 2.8 4.1 3.3 3.2
2022 1.7 0.5 3.2 2.4 2.2
2023 0.8 3.3 3.7 2.7 2.9
2024 4.0 3.6 4.0 2.7 3.6


Figure 4. Annual weighted prevalence of functional difficulties among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2019–2024. Dashed line shows national prevalence. Some yearly regional estimates did not meet National Center for Health Statistics reliability standards and should be interpreted with caution: 2020 Northeast data for difficulty learning, remembering, and concentrating; 2020 Midwest data for difficulty with behavioral control and making friends; and 2021 Midwest data for difficulty concentrating.

Return to Article

Annual weighted prevalence of physical health and health care access among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2019–2024. Dashed line shows national prevalence. Some data did not meet National Center for Health Statistics standards for proportions and should be interpreted with caution: 2022 and 2024 Northeast data on fair/poor health; 2021 Northeast data on unmet medical needs; and Northeast 2019, 2022, 2023 and Midwest 2020 data on no health insurance.
Indicator/year Prevalence, %
Northeast Midwest South West National
Panel A. Fair/poor health
2019 2.8 3.6 3.2 3.0 3.2
2020 2.2 3.6 2.5 3.8 3.0
2021 1.8 1.7 3.7 3.6 3.0
2022 3.9 2.7 4.1 3.6 3.7
2023 1.1 2.1 3.4 3.8 2.9
2024 3.7 4.5 2.5 2.9 3.2
Panel B.Unmet medical needs
2019 0.6 0.7 1.9 1.1 1.2
2020 0.7 0.9 1.3 0.7 1.0
2021 0.0 1.7 1.3 1.8 1.3
2022 0.5 0.3 1.8 1.1 1.1
2023 0.4 0.7 1.7 1.6 1.3
2024 0.9 1.6 2.1 1.5 1.7
Panel C. Delayed medical care
2019 0.5 0.6 2.9 1.6 1.7
2020 0.7 1.2 1.2 1.8 1.3
2021 0.2 0.8 1.3 2.0 1.2
2022 0.5 0.7 1.5 1.1 1.1
2023 0.5 0.3 1.7 1.3 1.2
2024 0.7 2.0 2.7 2.1 2.1
Panel D. No usual source of care
2019 2.2 4.2 3.8 2.2 3.2
2020 0.3 2.7 2.7 3.2 2.5
2021 0.3 3.9 4.0 3.0 3.2
2022 1.7 2.6 3.7 3.0 3.0
2023 2.1 3.2 3.8 3.5 3.4
2024 0.4 2.8 4.6 2.5 3.1
Panel E. No health insurance
2019 2.8 4.0 7.9 5.6 5.7
2020 0.8 6.0 9.3 2.4 5.6
2021 1.5 3.3 6.9 3.4 4.5
2022 2.2 2.9 6.7 3.9 4.5
2023 2.8 1.8 6.4 3.8 4.3
2024 0.8 5.5 7.6 3.9 5.2


Figure 5. Annual weighted prevalence of physical health and health care access among US adolescents aged 12–17 years, by region, National Health Interview Survey, 2019–2024. Dashed line shows national prevalence. Some data did not meet National Center for Health Statistics standards for proportions and should be interpreted with caution: 2022 and 2024 Northeast data on fair/poor health; 2021 Northeast data on unmet medical needs; and Northeast 2019, 2022, 2023 and Midwest 2020 data on no health insurance.

Return to Article

Top


The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.